---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-173033"
form_type: "8-K"
ticker: "STIM"
cik: "0001227636"
company_name: "Neuronetics, Inc."
filed_at: "2025-08-05T23:59:59+00:00"
generated_at: "2026-05-17T20:28:55.483794+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Neuronetics Q2 rev $38.1M (+132% YoY); secures $10M additional debt; lowers liquidity requirement to $2M through Sep'26

## Summary
- Q2 2025 revenue $38.1M, up 132% YoY; adjusted pro forma growth 18%; net loss $(9.8)M ($0.15 loss per share).
- Record Greenbrook clinic revenue $23.0M; U.S. treatment session revenue $10.8M (pro forma +13%); shipped 41 NeuroStar systems.
- Received $10M Tranche 2A loan from Perceptive on Aug 1, 2025; minimum liquidity lowered to $2M through Sep 2026; still eligible for $5M more.
- Appointed Steven Pfanstiel as CFO effective July 15, 2025; succeeded Stephen Furlong.
- Guidance: Q3 rev $37-39M, FY rev $149-155M; FY operating expenses raised to $100-105M; cash flow positive expected in Q4 2025.

## SEC filing metadata
- accession: 0001193125-25-173033
- form_type: 8-K
- ticker: STIM
- cik: 0001227636
- company_name: Neuronetics, Inc.
- filed_at: 2025-08-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1227636/000119312525173033/0001193125-25-173033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1227636/000119312525173033/d72601d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-173033
- JSON: https://secwatch.observer/filing/0001193125-25-173033.json
- Plain text: https://secwatch.observer/filing/0001193125-25-173033.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.